Business Context and Reporting Period
The supplied filing is for Ambac Financial Group, Inc., not OCTAVE SPECIALTY GROUP INC. It is an unaudited Form 10-Q for the quarter ended March 31, 2022, filed May 10, 2022. Ambac operates three reportable businesses: runoff legacy financial guarantee insurance, specialty property and casualty insurance, and insurance distribution.
The legacy financial guarantee portfolio has been in runoff since 2008. The specialty P&C platform expanded through the January 2022 acquisition of three 21st Century insurance companies, while the insurance distribution segment includes the Xchange Benefits MGA.
Financial Metrics
| Metric | Q1 2022 | Q1 2021 / Prior Period |
|---|---|---|
| Total revenues | $119 million | $129 million |
| Pre-tax income | $3 million | $19 million |
| Net income attributable to common stockholders | $2 million | $17 million |
| Diluted EPS | $0.04 | $0.08 |
| Operating cash flow | $9 million provided | $40 million used |
| Investing cash flow | $136 million provided | $116 million provided |
| Financing cash flow | $52 million used | $69 million used |
| Ending cash, cash equivalents and restricted cash | $116 million | $42 million |
| Total assets | $11.531 billion | $12.303 billion at December 31, 2021 |
| Total stockholders’ equity | $974 million | $1.098 billion at December 31, 2021 |
| Long-term debt | $2.242 billion | $2.230 billion at December 31, 2021 |
Revenue included $15 million of net premiums earned, $5 million of net investment income, $10 million of net investment gains, $57 million of derivative gains, $9 million of commission income, and $22 million of income from variable interest entities. Expenses included $24 million of losses and loss expenses, $14 million of intangible amortization, $34 million of operating expenses, and $44 million of interest expense.
Other comprehensive loss was $127 million, driven primarily by $105 million of after-tax unrealized securities losses and $23 million of foreign-currency translation losses. Total comprehensive loss attributable to common stockholders was $125 million.
Adjusted earnings were $14 million, or $0.30 per diluted share, compared with $41 million, or $0.59 per diluted share, in the prior-year quarter. Adjusted book value was $841 million, or $18.07 per share, versus $874 million, or $18.88 per share at December 31, 2021.
Material Changes Versus the Prior Comparable Period
- Net investment income fell to $5 million from $49 million, reflecting losses on trading securities received in the Puerto Rico restructuring and weaker pooled-fund performance.
- Derivative gains increased to $57 million from $25 million, primarily because of rising interest rates and favorable hedge positioning.
- Losses and loss expenses increased to $24 million from $8 million, mainly because Ambac reduced estimated RMBS representation-and-warranty recoveries by $224 million, partially offset by favorable Puerto Rico-related public-finance development.
- The Puerto Rico restructuring generated an estimated $198 million favorable effect in first-quarter results, including a net loss benefit and a gain from consolidating newly established trusts, partly offset by valuation losses on securities received and intangible amortization.
- Gross premiums written increased to $30 million from negative $2 million, driven by the specialty P&C business. Specialty P&C gross premiums written were $24 million, and insurance distribution premiums placed increased 12% to $45 million.
- Legacy financial guarantee net par outstanding declined 3% to $27.118 billion from $28.020 billion; adversely classified credit net par declined 7% to $5.884 billion.
- Cash and restricted cash increased to $116 million from $23 million at year-end, primarily due to investing cash flows and operating cash generation. The company also reported $243 million of AFG net assets excluding equity investments in subsidiaries.
Guidance, Outlook, Risks and Unusual Items
The filing does not provide formal quantitative earnings guidance. Management expects the legacy financial guarantee segment to continue running off, generally reducing premium earnings, investment income, operating expenses, and intangible amortization. The specialty P&C platform and insurance distribution businesses are intended to provide growth and diversification.
- Puerto Rico: The March 15, 2022 Commonwealth restructuring materially reduced Ambac-insured exposure. Remaining Puerto Rico net exposure was $784 million at March 31, 2022, primarily related to PRHTA. A PRHTA plan of adjustment was filed May 2, 2022, but its confirmation and ultimate recoveries remain uncertain.
- Reserve sensitivity: Management estimated that adverse stress scenarios for public-finance credits, including Puerto Rico, could increase loss reserves by approximately $220 million. Other stress scenarios could produce additional losses, and actual losses may exceed these estimates.
- RMBS recoveries: Recorded RMBS representation-and-warranty recoveries were $1.480 billion net of reinsurance. The filing states that failure to realize these recoveries could reduce stockholders’ equity from approximately $974 million to approximately negative $502 million.
- Debt and regulatory constraints: AAC surplus-note principal and interest payments require approval from the Wisconsin insurance regulator. In May 2022, the regulator declined approval for the scheduled June 7, 2022 payment; unpaid interest continues to accrue. Accrued and unpaid interest on third-party surplus notes was $593 million at March 31, 2022.
- Liquidity: Management believes near-term liquidity needs can be met, but AAC and Everspan are not expected to pay dividends to AFG in the foreseeable future. Future liquidity depends on premiums, investment maturities, recoveries, asset sales, and debt obligations.
- Specialty P&C profitability: The segment reported a $2 million pretax loss and a 331.9% combined ratio. Management cited inflation, social inflation, supply-chain disruption, labor shortages, and claims uncertainty as risks.
- Derivatives: All ratings-based collateral and termination triggers have been activated. AFS had $119 million of net collateral and margin posted at March 31, 2022.
- Share repurchases: The board authorized a $20 million repurchase program; no plan repurchases occurred during the quarter. From April 1 through May 10, 2022, the company repurchased 1.505 million shares for $13.2 million.
- COVID-19, foreign exchange, interest rates, litigation, regulatory intervention, LIBOR transition, cyber risk, and the Russia-Ukraine conflict remain identified risks. Management stated that Russia and Ukraine exposure was not material as of the filing.
Most Important Facts for Investors to Verify
- Confirm the issuer identity: the supplied filing is Ambac Financial Group, Inc., while the request metadata names OCTAVE SPECIALTY GROUP INC.
- Assess the collectability and timing of the $1.480 billion net RMBS representation-and-warranty recovery asset.
- Monitor PRHTA restructuring confirmation, Puerto Rico recovery values, and potential reserve volatility.
- Review AAC’s ability to service $2.242 billion of consolidated long-term debt and the regulatory status of surplus-note payments.
- Evaluate liquidity after the $393 million of second-quarter 2022 payments related to accelerated PRIFA and CCDA bonds.
- Track specialty P&C underwriting profitability, combined ratios, inflation effects, and the integration of the 21st Century acquisitions.
- Reconcile GAAP earnings with adjusted earnings and adjusted book value, particularly the effects of intangible amortization, foreign exchange, and accumulated other comprehensive losses.